Current Report Filing (8-k)
26 Avril 2016 - 3:02PM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
8-K
CURRENT
REPORT
Pursuant
to Section 13 or 15(d) of the
Securities
Exchange Act of 1934
Date
of report (Date of earliest event reported): April 26, 2016
CardioGenics
Holdings Inc.
(Exact
Name of Registrant as Specified in its Charter)
Nevada
|
|
000-28761
|
|
88-0380546
|
(State
or other jurisdiction
of
incorporation)
|
|
(Commission
File Number)
|
|
(I.R.S.
Employer
Identification)
|
6295
Northam Drive, Unit 8, Mississauga, Ontario, L4V 1W8
(Address
of Principal Executive Offices)(Zip Code)
Registrant’s
telephone number, including area code: 905.673.8501
(Former
Name or Former Address, if Changed Since Last Report)
Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant
under any of the following provisions (
see
General Instruction A.2. below):
[ ]
|
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
|
[ ]
|
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
|
|
[ ]
|
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
|
|
[ ]
|
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
TABLE
OF CONTENTS
Item
8.01 Other Events
SIGNATURE
Item
8.01 – Other Events
On
November 2, 2015 CardioGenics Holdings Inc., a Nevada corporation (the “
Company
”), 2489528 Ontario Inc., an
Ontario corporation and indirect subsidiary of the Company (“
Acquisition Sub
”) (collectively, the “
Purchasers
”),
Plasticap and 1731861 Ontario Inc., an Ontario corporation (“
173 Corp
”) (collectively, the “
Sellers
”)
entered into an asset purchase agreement pursuant to which Acquisition Sub acquired all of the assets of Plasticap and 173 Corp
(the “
Asset Purchase Agreement
”). Also on November 2, 2015 the Purchasers and the Sellers closed the sale and
purchase of all of the assets of Sellers by Acquisition Sub, pursuant to the terms of the Asset Purchase Agreement, all as more
fully described in the Current Report on Form 8-K filed by the Company on November 9, 2015.
Following
the closing, the Sellers, alleging breach of certain terms and conditions of the Asset Purchase Agreement by the Purchasers, refused
to provide operational control of the purchased assets to Acquisition Sub despite the Purchasers’ requests and efforts to
obtain such control. As the Purchasers fully dispute the Sellers’ allegations, the Purchasers’ Canadian attorneys
made a written demand on the Sellers’ attorneys dated April 20, 2016 for repayment, no later than April 29, 2016, of CDN
$379,288.84 paid to Sellers by the Company. If the Sellers do not repay such amount by the specified date, the Purchasers intend
to pursue their legal remedies against the Sellers.
SIGNATURE
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf
by the undersigned hereunto duly authorized.
|
CARDIOGENICS
HOLDINGS INC.
|
|
|
|
|
By:
|
/s/
Yahia Gawad
|
|
Name:
|
Yahia Gawad
|
|
Title:
|
Chief Executive
Officer
|
Dated:
April 26, 2016
CardioGenics (CE) (USOTC:CGNH)
Graphique Historique de l'Action
De Nov 2024 à Déc 2024
CardioGenics (CE) (USOTC:CGNH)
Graphique Historique de l'Action
De Déc 2023 à Déc 2024
Real-Time news about CardioGenics Holdings Inc (CE) (OTCMarkets): 0 recent articles
Plus d'articles sur Cardiogenics Holdings Inc.